More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-4 of 4 results

  • www.targetals.org
  • 1
  • 1
  • 62
Founded in 2013, Target ALS is a 501(c)(3) medical research foundation committed to the search for effective treatments for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease... We provide access to multiple CNS sub-regions from..
Relevance: 5.6644278
  • www.ionispharma.com
  • 2
  • 6
  • 48
Akcea is a wholly owned subsidiary of Ionis. Akcea commercializes TEGSEDI™ (inotersen) and WAYLIVRA® (volanesorsen), and with Ionis, is advancing a mature pipeline of novel medicines discovered by Ionis and based on Ionis' proprietary antisense..
Relevance: 5.2236333
  • www.ionispharma.com
  • 7
  • 6
  • 64
As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and providing hope for patients. Our broadly applicable, versatile, and rapidly advancing technology..
Relevance: 3.817109
  • www.ionispharma.com
  • 7
  • 6
  • 62
As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and providing hope for patients. Our broadly applicable, versatile, and rapidly advancing technology..
Relevance: 3.817109